RxDoctor Payments Data

Richard Fuhler

Internal Medicine · Mobile, ALNPI 1922110535

Payments from drug & device makers

$4,504in general payments, 2019–2025

Across 284 payments — averaging $15.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neos Therapeutics, LP$970
  • Corium, LLC$892
  • Ironshore Pharmaceuticals Inc.$696
  • Tris Pharma Inc$567
  • Takeda Pharmaceuticals U.S.A., Inc.$383
  • Supernus Pharmaceuticals, Inc.$249
  • plus $747 from 7 others

What the payments were for

  • Food & beverage$4,504100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,504 in reported general payments places this provider in the 80th percentile of 1,533 internal medicine providers in Alabama.

See all internal medicine providers in Alabama

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lisdexamfetamine Dimesylate15$3,475
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine30$1,554
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine24$573

Paid to pharmacies, not to this prescriber.

Other internal medicine in Mobile

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →